Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.
Nov 9, 2021
0
19
Pharmaceutical company Pfizer has announced the results of clinical trials of its new oral antiviral treatment against COVID-19. The new drug candidate, Paxlovid, proved to be effective against the SARS-CoV-2 virus, which ...
Nov 8, 2021
0
9
Are COVID-19 boosters the same as the original vaccines?
Nov 4, 2021
0
7
U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
Nov 1, 2021
0
2
Australian children aged five to 11 could begin receiving the Pfizer vaccine by the end of November, with the nation's regulator currently reviewing the health and safety data.
Oct 28, 2021
0
4
The use of so-called "mix and match" COVID-19 vaccine boosters may give a stronger immune response than sticking to one type of jab, the EU's drug watchdog said on Thursday.
Oct 21, 2021
0
3
A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday.
Oct 21, 2021
0
2
People who received Johnson & Johnson's COVID-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.
Oct 14, 2021
0
29
COVID-19 vaccine choices are getting more complicated. So don't feel bad if you are confused about the different COVID-19 vaccines and who's eligible for what. In addition to the three original vaccines approved by the Food ...
Oct 8, 2021
0
41
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in youngsters and help schools ...
Oct 7, 2021
0
2
